Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
Go back to Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results| GLOBUS MEDICAL, Inc. (NYSE: GMED) | Delayed: 86.91 +1.24 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.67 | 52 Week High | $28.60 | |||
| Open | $85.57 | 52 Week Low | $19.25 | |||
| Day High | $87.16 | P/E | 119.05 | |||
| Day Low | $85.26 | EPS | $0.73 | |||
| Volume | 930,801 | |||||
| (NYSE: NVRO) | Delayed: 5.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.84 | 52 Week High | $106.93 | |||
| Open | $5.84 | 52 Week Low | $47.07 | |||
| Day High | $5.84 | P/E | N/A | |||
| Day Low | $5.84 | EPS | $0.00 | |||
| Volume | 1,874,756 | |||||
